Imatinib Completed Phase 1 / 2 Trials for Small Intestine Cancer / Gastrointestinal Stromal Tumors / Cancer of the Ovary / Sarcomas / Endometrial Cancers Treatment

CompletedTreatment1 / 2 IdentifierTitleDrugs
NCT00135005Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)
NCT00441155Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib